Announcements
The Company announces discontinuation of the Phase II Study of OBI-888
1.Date of occurrence of the event:2022/07/01 2.New drug name or code:Passive Immunotherapeutic Monoclonal Antibody, OBI-888 3.Indication:An immunotherapeutic monoclonal antibody targeting Globo H for the treatment of cancer. Clinicaltrials.gov: https://www.clinicaltrials.gov/ct2/show/NCT03573544 https://www1.cde.org.tw/ct_taiwan/search_case2.php?caseno_ind%5B1%5D=6213 …
Announcement of the status of implementation of the commitments during the up-listing at Taipei Exchange
1.Date of occurrence of the event:2022/06/27 2.Company name:OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:Not applicable. 5.Cause of occurrence:Announcement of the …
The Company’s Board of Directors nominated Michael Chang to serve as the Chairman of the Board
1.Date of the board of directors resolution or date of occurrence of the change:2022/06/27 2.Position (Please enter chairperson or president/general manager):Chairman 3.Name of the previous position holder:Michael Chang 4.Resume of …
Announcement of 2022 shareholders’ meeting resolution to lift the non-competition restrictions for new directors
1.Date of the shareholders’ meeting resolution:2022/06/27 2.Name and title of the managerial officer with permission to engage in competitive conduct: Director Michael Chang Director Tamon Tseng, Representative of Yi Tai …
Announcement of 5th Remuneration Committee Members
1.Date of occurrence of the change:2022/06/27 2.Name of the functional committees:Remuneration Committee 3.Name of the previous position holder: (1)Jerry Fong (2)Taychang Wang (3)Howard Lee 4.Resume of the previous position holder: …
Announcement of 4th Audit Committee Members
1.Date of occurrence of the change:2022/06/27 2.Name of the functional committees:Audit Committee 3.Name of the previous position holder: (1)Jerry Fong (2)Taychang Wang (3)Howard Lee 4.Resume of the previous position holder: …
Announcement of Re-election of directors at the 2022 annual shareholders’ meeting
1.Date of occurrence of the change:2022/06/27 2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor):Natural-person director, institutional director and independent director. 3.Title …
Announcement of the Company’s important resolutions of the 2022 annual shareholders’ meeting
1.Date of the shareholders’ meeting:2022/06/27 2.Important resolutions I.Profit distribution/deficit compensation:Acknowledgement of the 2021 Earnings Distribution Loss Off-setting. 3.Important resolutions II.Amendments of the company charter:Resolution of amendment of the Company’s “Articles …
Announcement on behalf of AP Biosciences of the BOD’s resolution to issue common shares through cash capital increase and the reference date
1.Date of the resolution by the board of directors or decision by the Company:2022/06/22 2.Number of shares issued:16,000,000 common shares 3.Par value per share:10 NTD 4.Total monetary value of the …
Announcement on behalf of Amaran of important resolutions of the 2022 annual shareholders’ meeting
1.Date of the shareholders’ meeting:2022/06/16 2.Important resolutions I.Profit distribution/deficit compensation:Acknowledgement of the 2021 Deficit Compensation. 3.Important resolutions II.Amendments of the company charter:None 4.Important resolutions III.Business report and financial statements:Acknowledgement of …